Clinical Trial Update: Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043) [Phase 3]

View source ↗

Summary

Phase 3 trial update of vaniprevir with pegylated interferon and ribavirin in treatment-naïve Japanese patients with chronic hepatitis C, with trial completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)
• vaniprevir (vaniprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2014-10-06